| Title : Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms - Hecht_2022_MAbs_14_2135183 |
| Author(s) : Hecht ES , Mehta S , Wecksler AT , Aguilar B , Swanson N , Phung W , Dubey Kelsoe A , Benner WH , Tesar D , Kelley RF , Sandoval W , Sreedhara A |
| Ref : MAbs , 14 :2135183 , 2022 |
| Abstract : Hecht_2022_MAbs_14_2135183 |
| ESTHER : Hecht_2022_MAbs_14_2135183 |
| PubMedSearch : Hecht_2022_MAbs_14_2135183 |
| PubMedID: 36284469 |
| Title : Novel sorafenib-based structural analogues: in-vitro anticancer evaluation of t-MTUCB and t-AUCMB - Wecksler_2014_Anticancer.Drugs_25_433 |
| Author(s) : Wecksler AT , Hwang SH , Wettersten HI , Gilda JE , Patton A , Leon LJ , Carraway KL, 3rd , Gomes AV , Baar K , Weiss RH , Hammock BD |
| Ref : Anticancer Drugs , 25 :433 , 2014 |
| Abstract : Wecksler_2014_Anticancer.Drugs_25_433 |
| ESTHER : Wecksler_2014_Anticancer.Drugs_25_433 |
| PubMedSearch : Wecksler_2014_Anticancer.Drugs_25_433 |
| PubMedID: 24525589 |
| Title : Effect of soluble epoxide hydrolase polymorphism on substrate and inhibitor selectivity and dimer formation - Morisseau_2014_J.Lipid.Res_55_1131 |
| Author(s) : Morisseau C , Wecksler AT , Deng C , Dong H , Yang J , Lee KS , Kodani SD , Hammock BD |
| Ref : J Lipid Res , 55 :1131 , 2014 |
| Abstract : Morisseau_2014_J.Lipid.Res_55_1131 |
| ESTHER : Morisseau_2014_J.Lipid.Res_55_1131 |
| PubMedSearch : Morisseau_2014_J.Lipid.Res_55_1131 |
| PubMedID: 24771868 |
| Title : Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors - Hwang_2013_Bioorg.Med.Chem.Lett_23_3732 |
| Author(s) : Hwang SH , Wecksler AT , Zhang G , Morisseau C , Nguyen LV , Fu SH , Hammock BD |
| Ref : Bioorganic & Medicinal Chemistry Lett , 23 :3732 , 2013 |
| Abstract : Hwang_2013_Bioorg.Med.Chem.Lett_23_3732 |
| ESTHER : Hwang_2013_Bioorg.Med.Chem.Lett_23_3732 |
| PubMedSearch : Hwang_2013_Bioorg.Med.Chem.Lett_23_3732 |
| PubMedID: 23726028 |
| Title : Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase - Hwang_2011_J.Med.Chem_54_3037 |
| Author(s) : Hwang SH , Wagner KM , Morisseau C , Liu JY , Dong H , Wecksler AT , Hammock BD |
| Ref : Journal of Medicinal Chemistry , 54 :3037 , 2011 |
| Abstract : Hwang_2011_J.Med.Chem_54_3037 |
| ESTHER : Hwang_2011_J.Med.Chem_54_3037 |
| PubMedSearch : Hwang_2011_J.Med.Chem_54_3037 |
| PubMedID: 21434686 |
| Title : Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy - Inoue_2011_Cancer.Biol.Ther_12_827 |
| Author(s) : Inoue H , Hwang SH , Wecksler AT , Hammock BD , Weiss RH |
| Ref : Cancer Biol Ther , 12 :827 , 2011 |
| Abstract : Inoue_2011_Cancer.Biol.Ther_12_827 |
| ESTHER : Inoue_2011_Cancer.Biol.Ther_12_827 |
| PubMedSearch : Inoue_2011_Cancer.Biol.Ther_12_827 |
| PubMedID: 21878748 |